Further Information
MARK2, PAR-1, MAP/microtubule affinity-regulating kinase 2, EMK1, MGC99619, ELKL motif kinase, ELKL motif kinase 1, protein-serine/threonine kinase, serine/threonine kinase
Peptide ELISA: antibody detection limit dilution 1:16000.Western Blot:Approx 70kDa band observed in Human Brain (Cerebellum) lysates (calculated MW of 77.6kDa according to NP_004945.3). Recommended concentration: 0.3-1ug/ml.
- Depasquale I, Thompson WD. Prognosis in human melanoma: PAR-1 expression is superior to other coagulation components and VEGF. Histopathology. 2008 Mar;52(4):500-9.
Supplied at 0.5 mg/ml in Tris saline, 0.02% sodium azide, pH7.3 with 0.5% bovine serum albumin.
Aliquot and store at -20?C. Minimize freezing and thawing.
500 ug/mL
Unconjugated
Optimal dilutions/concentrations should be determined by the end user. The information provided is a guideline for product use. Optimal dilutions/concentrations should be determined by the end user. The information provided is a guideline for product use. This product is for research use only.
Expected Species Reactivity based on sequence homology: Mouse, Rat, Cow
The immunogen for this antibody is: C-QNGKDSTAPQR
2011
MAP/microtubule affinity-regulating kinase 2
MARK2
Homo sapiens
Liquid
NP_004945.4, NP_001156768.1, NP_001156769.1
86990432
Purified from goat serum by ammonium sulphate precipitation followed by antigen affinity chromatography using the immunizing peptide.
This antibody is expected to recognise isoform c (NP_004945.4), isoform e (NP_001156768.1) and isoform f (NP_001156769.1).
Q7KZI7